MedTrace Logo

"SVEAT" Chest Pain Scoring System

NCT03511430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 370

Last updated 2018-10-11

No results posted yet for this study

Summary

This is a prospective, observational study to assess the efficacy of the newly developed SVEAT scoring system in identifying low-risk patients who may be eligible for early discharge. Various elements of clinical information including Symptoms, Vascular history, EKG, Age and Troponin values will be checked and entered on the scoring form to calculate the SVEAT risk score. Additionally, HEART score and TIMI risk score will be calculated for the same subjects.

The primary aim is to assess the positive and negative predictive values for the SVEAT index for cardiovascular events and compare it to the HEART and TIMI Scores.

Conditions

Sponsors & Collaborators

  • Renown Regional Medical Center

    collaborator OTHER

  • University of Nevada, Reno

    lead OTHER

Principal Investigators

  • Chanwit Roongsritong, MD, FACC · University of Nevada, Reno

Eligibility

Min Age
24 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2018-09-15
Completion
2018-10-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03511430 on ClinicalTrials.gov